Dishman Carbogen Amcis Limited Cash Flow Conversion Efficiency
Dishman Carbogen Amcis Limited cash flow conversion efficiency. Based on the latest financial reports, Dishman Carbogen Amcis Limited (DCAL) has a cash flow conversion efficiency ratio of 0.046x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.95 Billion ≈ $31.93 Million USD) by net assets (Rs63.65 Billion ≈ $688.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Dishman Carbogen Amcis Limited (2005–2025)
Cash flow conversion efficiency of Dishman Carbogen Amcis Limited from 2005 to 2025. This chart illustrates how Dishman Carbogen Amcis Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Dishman Carbogen Amcis Limited stock quote for real-time trading data and today's change.
Dishman Carbogen Amcis Limited Cash Flow Conversion Ratio Explained
Dishman Carbogen Amcis Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Dishman Carbogen Amcis Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Dishman Carbogen Amcis Limited ranked by their cash flow conversion efficiency. Also see market value of Dishman Carbogen Amcis Limited for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cerro de Pasco Resources Inc.
V:CDPR
|
N/A |
|
LCY Technology Corp
TW:4989
|
-0.089x |
|
Shanghai Kaytune Industrial Co.Ltd
SHE:301001
|
N/A |
|
Ouro Fino Saúde Animal Participações S.A
SA:OFSA3
|
0.166x |
|
Bonduelle S.C.A.
PA:BON
|
0.324x |
|
HomeStreet Inc
NASDAQ:HMST
|
-0.024x |
|
Hangzhou Hopechart Iot Technology
SHG:688288
|
0.038x |
|
Drugs Made In America Acquisition Corp. Ordinary Shares
NASDAQ:DMAA
|
-0.002x |
Annual Cash Flow Conversion Efficiency for Dishman Carbogen Amcis Limited (2005–2025)
The table below shows the annual cash flow conversion efficiency of Dishman Carbogen Amcis Limited from 2005 to 2025. Review Dishman Carbogen Amcis Limited free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs58.32 Billion ≈ $630.66 Million |
Rs3.75 Billion ≈ $40.58 Million |
0.064x | -5.70% |
| 2024-03-31 | Rs56.27 Billion ≈ $608.59 Million |
Rs3.84 Billion ≈ $41.52 Million |
0.068x | +49.05% |
| 2023-03-31 | Rs58.10 Billion ≈ $628.29 Million |
Rs2.66 Billion ≈ $28.76 Million |
0.046x | -28.42% |
| 2022-03-31 | Rs55.49 Billion ≈ $600.10 Million |
Rs3.55 Billion ≈ $38.38 Million |
0.064x | -28.91% |
| 2021-03-31 | Rs56.99 Billion ≈ $616.31 Million |
Rs5.13 Billion ≈ $55.44 Million |
0.090x | -12.14% |
| 2020-03-31 | Rs57.15 Billion ≈ $618.06 Million |
Rs5.85 Billion ≈ $63.28 Million |
0.102x | +95.28% |
| 2019-03-31 | Rs53.79 Billion ≈ $581.73 Million |
Rs2.82 Billion ≈ $30.50 Million |
0.052x | +18.26% |
| 2018-03-31 | Rs51.07 Billion ≈ $552.34 Million |
Rs2.26 Billion ≈ $24.49 Million |
0.044x | -29.48% |
| 2017-03-31 | Rs48.14 Billion ≈ $520.61 Million |
Rs3.03 Billion ≈ $32.73 Million |
0.063x | -67.24% |
| 2016-03-31 | Rs14.52 Billion ≈ $157.03 Million |
Rs2.79 Billion ≈ $30.13 Million |
0.192x | -16.61% |
| 2015-03-31 | Rs12.42 Billion ≈ $134.30 Million |
Rs2.86 Billion ≈ $30.91 Million |
0.230x | -19.70% |
| 2014-03-31 | Rs12.02 Billion ≈ $130.01 Million |
Rs3.45 Billion ≈ $37.26 Million |
0.287x | +120.10% |
| 2013-03-31 | Rs10.55 Billion ≈ $114.06 Million |
Rs1.37 Billion ≈ $14.85 Million |
0.130x | -21.25% |
| 2012-03-31 | Rs9.29 Billion ≈ $100.45 Million |
Rs1.54 Billion ≈ $16.61 Million |
0.165x | -28.31% |
| 2011-03-31 | Rs8.79 Billion ≈ $95.08 Million |
Rs2.03 Billion ≈ $21.93 Million |
0.231x | -40.14% |
| 2010-03-31 | Rs7.84 Billion ≈ $84.81 Million |
Rs3.02 Billion ≈ $32.68 Million |
0.385x | +105.98% |
| 2009-03-31 | Rs7.04 Billion ≈ $76.18 Million |
Rs1.32 Billion ≈ $14.25 Million |
0.187x | +120.69% |
| 2008-03-31 | Rs5.73 Billion ≈ $62.02 Million |
Rs486.09 Million ≈ $5.26 Million |
0.085x | -36.93% |
| 2007-03-31 | Rs3.18 Billion ≈ $34.39 Million |
Rs427.32 Million ≈ $4.62 Million |
0.134x | +64.50% |
| 2006-03-31 | Rs1.89 Billion ≈ $20.39 Million |
Rs154.02 Million ≈ $1.67 Million |
0.082x | +151.73% |
| 2005-03-31 | Rs1.47 Billion ≈ $15.91 Million |
Rs-232.28 Million ≈ $-2.51 Million |
-0.158x | -- |
About Dishman Carbogen Amcis Limited
Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical and healthcare industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It offers cholesterol and vitamin D analogs; generic active pharmaceutical ingredients for diagnostics, ophthalmic treatments, laxatives, organop… Read more